Literature DB >> 23769217

HIV pre-exposure prophylaxis in injecting drug users.

Salim S Abdool Karim1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23769217     DOI： 10.1016/S0140-6736(13)61140-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Antibodies for HIV prevention in young women.

Authors:  Salim S Abdool Karim; Quarraisha Abdool Karim; Cheryl Baxter
Journal:  Curr Opin HIV AIDS       Date:  2015-05       Impact factor: 4.283

Review 2.  Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention.

Authors:  Kathryn E Stephenson; Kshitij Wagh; Bette Korber; Dan H Barouch
Journal:  Annu Rev Immunol       Date:  2020-04-26       Impact factor: 32.481

3.  Tailored combination prevention packages and PrEP for young key populations.

Authors:  Audrey Pettifor; Nadia L Nguyen; Connie Celum; Frances M Cowan; Vivian Go; Lisa Hightow-Weidman
Journal:  J Int AIDS Soc       Date:  2015-02-26       Impact factor: 5.396

4.  Commentary: the value of PrEP for people who inject drugs.

Authors:  Rosalind L Coleman; Susie McLean
Journal:  J Int AIDS Soc       Date:  2016-10-18       Impact factor: 5.396

5.  M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID.

Authors:  Valérie Martel-Laferrière; Daniel J Feaster; Lisa R Metsch; Bruce R Shackman; Christine Loignon; Bohdan Nosyk; Hansel Tookes; Czarina N Behrends; Nelson Arruda; Oluleye Adigun; Marie-Eve Goyer; Michael A Kolber; Jean-Francois Mary; Allan E Rodriguez; Iveth G Yanez; Yue Pan; Rania Khemiri; Lauren Gooden; Aïssata Sako; Julie Bruneau
Journal:  Trials       Date:  2022-04-23       Impact factor: 2.728

6.  HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities.

Authors:  Ayesha B M Kharsany; Quarraisha A Karim
Journal:  Open AIDS J       Date:  2016-04-08

Review 7.  Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?

Authors:  Glenda E Gray; Fatima Laher; Tanya Doherty; Salim Abdool Karim; Scott Hammer; John Mascola; Chris Beyrer; Larry Corey
Journal:  PLoS Biol       Date:  2016-03-02       Impact factor: 8.029

Review 8.  Combining biomedical preventions for HIV: Vaccines with pre-exposure prophylaxis, microbicides or other HIV preventions.

Authors:  Janet M McNicholl
Journal:  Hum Vaccin Immunother       Date:  2016-12       Impact factor: 3.452

9.  Genital inflammation undermines the effectiveness of tenofovir gel in preventing HIV acquisition in women.

Authors:  Lyle R McKinnon; Lenine J Liebenberg; Nonhlanhla Yende-Zuma; Derseree Archary; Sinaye Ngcapu; Aida Sivro; Nico Nagelkerke; Jose Gerardo Garcia Lerma; Angela D Kashuba; Lindi Masson; Leila E Mansoor; Quarraisha Abdool Karim; Salim S Abdool Karim; Jo-Ann S Passmore
Journal:  Nat Med       Date:  2018-02-26       Impact factor: 53.440
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.